http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-013441-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14
filingDate 1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2000-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-013441-A1
titleOfInvention AN IMIDAZOQUINOXALINE COMPOUND, METHOD FOR THE TREATMENT OF A SUFFERING OR DISORDER ASSOCIATED WITH THE THYROSINAKINASE PROTEIN, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS FOR PREPARING SUCH COMPOUNDS AND THEIR INTERMEDIARIES
abstract Novel imidazoquinoxalines (I) are disclosed, where R1, R2, R3, R4, R5 and p are as disclosed in the description, and salts thereof, pharmaceutical compositions containing such compounds, methods for preparing and using said compounds in the treatment of conditions or disorders associated with the protein tyrosine kinase, such as immunological disorders.
priorityDate 1997-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411299232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136080001

Total number of triples: 16.